United States · Platforms & data · The Motley Fool

Aquestive (AQST) Q3 2026 Earnings Call Transcript

Published by The Motley Fool · United States 55 min ago

Anaphylm's March 2027 FDA date anchors a launch push backed by new funding.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

IPG Photonics (NASDAQ:IPGP) Reaches New 1-Year Low Following Analyst Downgrade

Hospital stocks rally while drugmakers brace for scrutiny. Here’s what the Democratic wave means for healthcare.

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Gübre Fabrikaları Reports Share Buyback, Holdings Reach 1.1164%

CRWV Stock Drops Over 9% And Its Bonds Tumble After Democrat Wave Hints Towards Slower Data Center Builds